RETRACTED: SphK1 Regulates Proinflammatory Responses Associated with Endotoxin and Polymicrobial Sepsis (Retracted Article)

被引:114
作者
Puneet, Padmam [1 ]
Yap, Celestial T. [1 ]
Wong, Lingkai [2 ]
Yulin, Lam [2 ]
Koh, Dow Rhoon [1 ]
Moochhala, Shabbir [3 ]
Pfeilschifter, Josef [4 ]
Huwiler, Andrea [5 ]
Melendez, Alirio J. [1 ,6 ]
机构
[1] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore
[2] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore
[3] Def Med & Environm Res Inst, DSO Natl Labs, Singapore 117510, Singapore
[4] Univ Hosp, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany
[5] Univ Bern, Inst Pharmacol, CH-3010 Bern, Switzerland
[6] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland
基金
英国医学研究理事会;
关键词
SPHINGOSINE KINASE 1; FC-GAMMA-RI; INFLAMMATORY RESPONSES; CECAL LIGATION; CA2+ SIGNALS; MODULATION; ACTIVATION; RECEPTOR; THERAPY; EPSILON;
D O I
10.1126/science.1188635
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
During sepsis, activation of phagocytes leads to the overproduction of proinflammatory cytokines, causing systemic inflammation. Despite substantial information regarding the underlying molecular mechanisms that lead to sepsis, several elements in the pathway remain to be elucidated. We found that the enzyme sphingosine kinase 1 (SphK1) is up-regulated in stimulated human phagocytes and in peritoneal phagocytes of patients with severe sepsis. Blockade of SphK1 inhibited phagocyte production of endotoxin-induced proinflammatory cytokines. We observed protection against sepsis in mice treated with a specific SphK1 inhibitor that was enhanced by treatment with a broad-spectrum antibiotic. These results demonstrated a critical role for SphK1 in endotoxin signaling and sepsis-induced inflammatory responses and suggest that inhibition of SphK1 is a potential therapy for septic shock.
引用
收藏
页码:1290 / 1294
页数:5
相关论文
共 26 条
[1]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[2]   Protein kinase Cε is required for macrophage activation and defense against bacterial infection [J].
Castrillo, A ;
Pennington, DJ ;
Otto, F ;
Parker, PJ ;
Owen, MJ ;
Boscá, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1231-1242
[3]   Mediator modulation therapy of severe sepsis and septic shock: Does it work? [J].
Dellinger, RP ;
Parrillo, JE .
CRITICAL CARE MEDICINE, 2004, 32 (01) :282-286
[4]   Risk and the efficacy of antiinflammatory agents - Retrospective and confirmatory studies of sepsis [J].
Eichacker, PQ ;
Parent, C ;
Kalil, A ;
Esposito, C ;
Cui, X ;
Banks, SM ;
Gerstenberger, EP ;
Fitz, Y ;
Danner, RL ;
Natanson, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (09) :1197-1205
[5]  
ESKANDARI MK, 1992, J IMMUNOL, V148, P2724
[6]   Evolution of duplicate genes versus genetic robustness against null mutations [J].
Gu, X .
TRENDS IN GENETICS, 2003, 19 (07) :354-356
[7]   Cecal ligation and puncture [J].
Hubbard, WJ ;
Choudhry, M ;
Schwacha, MG ;
Kerby, JD ;
Rue, LW ;
Bland, KI ;
Chaudry, IH .
SHOCK, 2005, 24 :52-57
[8]   Anaphylatoxin signaling in human neutrophils - A key role for sphingosine kinase [J].
Ibrahim, FBM ;
Pang, SJ ;
Melendez, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :44802-44811
[9]   Innate immune recognition [J].
Janeway, CA ;
Medzhitov, R .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :197-216
[10]   Transcription control reprogramming in genetic backup circuits [J].
Kafri, R ;
Bar-Even, A ;
Pilpel, Y .
NATURE GENETICS, 2005, 37 (03) :295-299